Flexion Therapeutics Inc (FLXN)

19.27
NASDAQ : Health Care
Prev Close 18.94
Day Low/High 18.88 / 19.57
52 Wk Low/High 7.56 / 23.57
Avg Volume 298.40K
Exchange NASDAQ
Shares Outstanding 27.53M
Market Cap 521.37M
EPS -2.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Flexion Therapeutics Stock Sees Short Interest Decline 20%

Flexion Therapeutics Stock Sees Short Interest Decline 20%

The most recent short interest data has been released for the 11/30/2016 settlement date, which shows a 254,831 share decrease in total short interest for Flexion Therapeutics, Inc. , to 1,028,455, a decrease of 19.86% since 11/15/2016.

Commit To Buy Flexion Therapeutics At $10, Earn 17% Annualized Using Options

Commit To Buy Flexion Therapeutics At $10, Earn 17% Annualized Using Options

Investors considering a purchase of Flexion Therapeutics, Inc. shares, but tentative about paying the going market price of $17.89/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Flexion Therapeutics Announces Presentation Of Phase 3 Data Demonstrating That Extended-Release Zilretta™ Achieves Clinically Significant Improvement Of Pain, Stiffness And Function In Patients With Osteoarthritis Of The Knee

Flexion Therapeutics Announces Presentation Of Phase 3 Data Demonstrating That Extended-Release Zilretta™ Achieves Clinically Significant Improvement Of Pain, Stiffness And Function In Patients With Osteoarthritis Of The Knee

Podium Presentation at the AAHKS Annual Meeting Shows Zilretta Delivers Extended Relief Compared to Immediate-Release Steroid and Placebo

Insiders Seeing Green With FLXN At New 52-Week High

Insiders Seeing Green With FLXN At New 52-Week High

In trading on Thursday, shares of Flexion Therapeutics, Inc. touched a new 52-week high of $22.00/share.

Flexion Therapeutics Announces Appointment Of John Magee as Vice President Of Sales

Flexion Therapeutics Announces Appointment Of John Magee as Vice President Of Sales

- Magee is a seasoned pharmaceutical executive with significant experience building effective sales teams and launching products -

Seeing Some Good Action in Individual Stocks

Seeing Some Good Action in Individual Stocks

An update on the market and my stock of the week, TPI Composites.

Flexion (FLXN) Stock Plunged Today After Announcing Stock Offering

Flexion (FLXN) Stock Plunged Today After Announcing Stock Offering

Flexion (FLXN) stock closed sharply lower on Wednesday after announcing plans to raise $77 million from a stock offering.

Market Digging Metal and Mining Stocks

There is some good speculative trading and metals are the place to be.

Commit To Buy Flexion Therapeutics At $10, Earn 22.8% Annualized Using Options

Commit To Buy Flexion Therapeutics At $10, Earn 22.8% Annualized Using Options

Investors eyeing a purchase of Flexion Therapeutics, Inc. stock, but tentative about paying the going market price of $15.38/share, might benefit from considering selling puts among the alternative strategies at their disposal.